Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
April 8, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
April 7, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
April 7, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
April 7, 2020 3

Initial filing by director officer or owner of more than ten percent.

View HTML
March 12, 2020 10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 12, 2020 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
March 12, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
March 10, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
March 2, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2020 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us